International Stem Cell (ISCO) Total Liabilities (2016 - 2025)
Historic Total Liabilities for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $4.8 million.
- International Stem Cell's Total Liabilities fell 331.23% to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year decrease of 331.23%. This contributed to the annual value of $4.8 million for FY2024, which is 898.24% down from last year.
- As of Q3 2025, International Stem Cell's Total Liabilities stood at $4.8 million, which was down 331.23% from $5.1 million recorded in Q2 2025.
- Over the past 5 years, International Stem Cell's Total Liabilities peaked at $6.4 million during Q1 2021, and registered a low of $4.8 million during Q3 2025.
- Its 5-year average for Total Liabilities is $5.3 million, with a median of $5.3 million in 2023.
- Per our database at Business Quant, International Stem Cell's Total Liabilities skyrocketed by 1841.67% in 2021 and then tumbled by 1106.44% in 2022.
- Over the past 5 years, International Stem Cell's Total Liabilities (Quarter) stood at $5.2 million in 2021, then grew by 2.31% to $5.4 million in 2022, then decreased by 1.46% to $5.3 million in 2023, then fell by 8.98% to $4.8 million in 2024, then fell by 0.94% to $4.8 million in 2025.
- Its Total Liabilities stands at $4.8 million for Q3 2025, versus $5.1 million for Q2 2025 and $5.4 million for Q1 2025.